Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-457029
Filing Date
2016-02-10
Accepted
2016-02-10 13:07:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d103419dsc13g.htm SC 13G 30007
  Complete submission text file 0001193125-16-457029.txt   31510
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Subject) CIK: 0001264587 (see all company filings)

EIN.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87209 | Film No.: 161404351
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 TIMES SQUARE 42ND FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 42ND FLOOR NEW YORK NY 10036 800-541-5156
TimesSquare Capital Management, LLC (Filed by) CIK: 0001313816 (see all company filings)

EIN.: 201665304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G